Tissue repair fabric
View Patent ↗This invention is directed to prosthesis, which, when implanted into a mammalian patient, serves as a functioning replacement for a body part, or tissue structure, and will undergo controlled biodegradation occurring concomitantly with bioremodeling by the patient's living cells. The prosthesis is treated so that it is rendered non-antigenic so as not to elicit a significant humoral immune response. The prosthesis of this invention, in its various embodiments, thus has dual properties. First, it functions as a substitute body part, and second, it functions as bioremodeling template for the ingrowth of host cells.
1. A method of repairing or replacing a damaged tissue comprising:
implanting in a patient a non-antigenic prosthesis comprising two or more superimposed, bonded layers of collagenous tissue of each layer comprises tunica submucosa of small intestine, wherein the collagenous tissue does not include the tunica muscularis and tunica mucosa, wherein the two or more layers of collagenous tissue are separated from surrounding layers of the small intestine, wherein the two or more layers of collagenous tissue have been sterilized with peracetic acid and crosslinked with a crosslinking agent that permits bioremodeling, wherein the crosslinking agent is 1-ethyl-3-(3-dimethylaminopropyl) carbodiimidc hydrochloride, wherein the two or more layers of collagenous tissue are completely bioremodelable and when implanted into a mammalian patient undergo controlled biodegradation occurring with adequate living cell replacement such that the implanted prosthesis is remodeled by the patient's living cells, and wherein the implanted prosthesis is an abdominal wall patch, a pericardial repair patch, a hernia repair device, a vascular patch, an intracardiac patch or a replacement heart valve.
2. The method of claim 1 wherein the prosthesis is flat, tubular, or complex.
3. The method of claim 1 wherein sulfo-N-hydroxysuccinimide is added to the crosslinking agent.
4. The method of claim 1 wherein acetone is added to the crosslinking agent.
5. The method of claim 1 wherein the prosthesis is sterilized with peracetic acid.
6. The method of claim 1 wherein the prosthesis further contains pores.
7. The method of claim 1 wherein the prosthesis has one or more surfaces and wherein the one or more surfaces of said prosthesis are coated with a collagenous material which acts as a smooth flow surface.
8. The method of claim 1 wherein the prosthesis additionally contains an anticoagulant, one or more antibiotics, or one or more growth factors.
9. A method of repairing or replacing a damaged tissue comprising:
implanting in a patient a non-antigenic prosthesis comprising two or more superimposed, bonded layers of collagenous tissue, wherein each layer comprises tunica submucosa of small intestine, wherein the collagenous tissue does not include the tunica muscularis and tunica mucosa, wherein the two or more layers of collagenous tissue are separated from surrounding layers of the small intestine, wherein the two or more layers of collagenous tissue have been sterilized with peracetic acid and crosslinked with a crosslinking agent that permits bioremodeling, wherein the crosslinking agent is 1-ethyl-3-(3-dimethylaminooronyl) carbodiimide hydrochloride, wherein the two or more layers of collagenous tissue are completely bioremodelable and when implanted into a mammalian patient undergo controlled biodegradation occurring with adequate living cell replacement such that the implanted prosthesis is remodeled by the patient's living cells, and wherein the prosthesis is implanted to repair, augment, or replace diseased or damaged organs selected from the group consisting of abdominal wall, pericardium, hernias, bone, periosteum, perichondrium, intervertebral disc, articular cartilage, derrnis, epidermis, bowel, ligaments, tendons.
10. The method of, claim 9 wherein the prosthesis is flat, tubular, or complex.
11. The method of claim 9 wherein sulfia-N-hydroxysuccinimide is added to the crosslinking agent.
12. The method of claim 9 wherein acetone is added to the crosslinking agent.
13. The method of claim 9 wherein the prosthesis is sterilized with peraectie acid.
14. The method of claim 9 wherein the prosthesis further contains pores.
15. The method of claim 9 wherein the prosthesis has one or more surfaces and wherein the one or more surfaces of said prosthesis are coated with a collagenous material which acts as a smooth flow surface.
16. The method of claim 9 wherein the prosthesis additionally contains an anticoagulant, one or more antibiotics, or one or more growth factors.